Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Efficacy and Safety of Somatropin in SGA Children Due to IUGR

NCT00557336 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00557336
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00557336 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Efficacy and Safety of Somatropin in SGA Children Due to IUGR
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Completed
Start date
July 28, 2003
Completion date
June 29, 2005
Enrollment
160 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

foetal growth problem, small for gestational age